Optimind Pharma Corp. (CSE:OMND)

Canada · Delayed Price · Currency is CAD

0.0050

0.00 (0.00%)

At close: Sep 11, 2025

Market Cap	515.74K -6.0%
Revenue (ttm)	121.29K +2.5%
Net Income	-117.94K
EPS	-0.00
Shares Out	103.15M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	50,000
Open	0.0050
Previous Close	0.0050
Day's Range	0.0050 - 0.0050
52-Week Range	0.0050 - 0.0100
Beta	0.13
Analysts	n/a
Price Target	n/a
Est. Earnings	Oct 27, 2026

About Optimind Pharma

Optimind Pharma Corp. provides psychedelic therapies in Canada. The company offers treatment of post-traumatic stress syndrome, anxiety, depression, and other mental illnesses and disabilities through ketamine-assisted treatment and other psychedelic enhanced psychotherapy modalities. It also provides cannabis referrals. In addition, the company operates clinics. Optimind Pharma Corp. is headquartered in Toronto, Canada. [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

CEO David Goodman

Country Canada

Stock Exchange Canadian Securities Exchange

Ticker Symbol OMND

Full Company Profile

Financial Performance

In fiscal year 2026, Optimind Pharma's revenue was 121,293, an increase of 2.47% compared to the previous year's 118,368. Losses were -117,935, -45.35% less than in 2025.

Financial Statements